Colon capsule endoscopy investigation based on faecal haemoglobin concentration in symptomatic patients to detect bowel disease

Campbell MacLeod; Craig Mowat; Jemma Hudson; Judith Strachan; Angus James Mackintosh Watson

doi:10.1093/bjsopen/zrae007

Colon capsule endoscopy investigation based on faecal haemoglobin concentration in symptomatic patients to detect bowel disease

Campbell MacLeod, Craig Mowat, Jemma Hudson, Judith Strachan, Angus James Mackintosh Watson

Research output: Contribution to journal › Article › peer-review

Abstract

The faecal immunochemical test (FIT), which measures the concentration of faecal haemoglobin (f-Hb), is now advocated by the Association of Coloproctology of Great Britain and Ireland and the British Society of Gastroenterology for use in primary care as an adjunct to clinical acumen in the assessment of new bowel symptoms1. FIT is superior to symptoms at predicting the presence of significant bowel disease (SBD)2–4. Higher f-Hb concentrations correspond with an increased risk of harbouring colorectal pathology and as such can be used to prioritize patients for investigation...

Original language	English
Article number	zrae007
Number of pages	4
Journal	BJS Open
Volume	8
Issue number	1
Early online date	3 Jan 2024
DOIs	https://doi.org/10.1093/bjsopen/zrae007
Publication status	Published - Feb 2024

Bibliographical note

We would like to thank the biochemistry laboratory staff at Raigmore and Ninewells Hospital for processing and analysing FIT samples, and all the patients who participated in the ScotCap evaluation.

Data Availability Statement

The data sets generated during and analysed during the current study are not publicly available due to the clinical nature of the data, but are available from the corresponding author on reasonable request.

Keywords

Humans
Capsule Endoscopy
Colonoscopy
Crohn Disease
Colon
Hemoglobins/analysis

Access to Document

10.1093/bjsopen/zrae007Licence: CC BY

MacLeod_etal_BJSO_Colon_Capsule_Endoscopy_VOR
This is an Open Access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/), which permits unrestricted reuse, distribution, and reproduction in any medium, provided the original work is properly cited.
Final published version, 256 KBLicence: CC BY

Cite this

@article{6372321724c54312858b5b2d452fb2b4,

title = "Colon capsule endoscopy investigation based on faecal haemoglobin concentration in symptomatic patients to detect bowel disease",

abstract = "The faecal immunochemical test (FIT), which measures the concentration of faecal haemoglobin (f-Hb), is now advocated by the Association of Coloproctology of Great Britain and Ireland and the British Society of Gastroenterology for use in primary care as an adjunct to clinical acumen in the assessment of new bowel symptoms1. FIT is superior to symptoms at predicting the presence of significant bowel disease (SBD)2–4. Higher f-Hb concentrations correspond with an increased risk of harbouring colorectal pathology and as such can be used to prioritize patients for investigation...",

keywords = "Humans, Capsule Endoscopy, Colonoscopy, Crohn Disease, Colon, Hemoglobins/analysis",

author = "Campbell MacLeod and Craig Mowat and Jemma Hudson and Judith Strachan and Watson, {Angus James Mackintosh}",

note = "We would like to thank the biochemistry laboratory staff at Raigmore and Ninewells Hospital for processing and analysing FIT samples, and all the patients who participated in the ScotCap evaluation.",

year = "2024",

month = feb,

doi = "10.1093/bjsopen/zrae007",

language = "English",

volume = "8",

journal = "BJS Open",

issn = "2474-9842",

publisher = "Oxford University Press (OUP)",

number = "1",

}

TY - JOUR

T1 - Colon capsule endoscopy investigation based on faecal haemoglobin concentration in symptomatic patients to detect bowel disease

AU - MacLeod, Campbell

AU - Mowat, Craig

AU - Hudson, Jemma

AU - Strachan, Judith

AU - Watson, Angus James Mackintosh

N1 - We would like to thank the biochemistry laboratory staff at Raigmore and Ninewells Hospital for processing and analysing FIT samples, and all the patients who participated in the ScotCap evaluation.

PY - 2024/2

Y1 - 2024/2

N2 - The faecal immunochemical test (FIT), which measures the concentration of faecal haemoglobin (f-Hb), is now advocated by the Association of Coloproctology of Great Britain and Ireland and the British Society of Gastroenterology for use in primary care as an adjunct to clinical acumen in the assessment of new bowel symptoms1. FIT is superior to symptoms at predicting the presence of significant bowel disease (SBD)2–4. Higher f-Hb concentrations correspond with an increased risk of harbouring colorectal pathology and as such can be used to prioritize patients for investigation...

AB - The faecal immunochemical test (FIT), which measures the concentration of faecal haemoglobin (f-Hb), is now advocated by the Association of Coloproctology of Great Britain and Ireland and the British Society of Gastroenterology for use in primary care as an adjunct to clinical acumen in the assessment of new bowel symptoms1. FIT is superior to symptoms at predicting the presence of significant bowel disease (SBD)2–4. Higher f-Hb concentrations correspond with an increased risk of harbouring colorectal pathology and as such can be used to prioritize patients for investigation...

KW - Humans

KW - Capsule Endoscopy

KW - Colonoscopy

KW - Crohn Disease

KW - Colon

KW - Hemoglobins/analysis

U2 - 10.1093/bjsopen/zrae007

DO - 10.1093/bjsopen/zrae007

M3 - Article

C2 - 38364055

SN - 2474-9842

VL - 8

JO - BJS Open

JF - BJS Open

IS - 1

M1 - zrae007

ER -

Colon capsule endoscopy investigation based on faecal haemoglobin concentration in symptomatic patients to detect bowel disease

Abstract

Bibliographical note

Data Availability Statement

Keywords

Access to Document

Fingerprint

Cite this